ARCHIVES

In Brief: Oliverio Moves to DEA; Kushner Blass NIH Slow Pay; DeVita Welcomes Hawkin’s Probe

This article is from The Cancer Letter archive.

Vol. 07 No. 06 | February 6, 1981

Download PDF Visit The Full Archive

Related Articles

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

April 13, 1984

GAO Criticize NCI Contract Practices In Report On Cancer Control

July 25, 1980

Sullivan Confirmation Hearing Set For Feb. 1

January 27, 1989

TTF Increased Survival Compared To Chemotherapy

December 31, 2010

M.D. Anderson Must Evaluate 8 Patients In Controversial Study

May 31, 1996

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013